共 50 条
- [21] Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World Practice [J]. Diabetes Therapy, 2020, 11 : 1579 - 1589
- [23] Short-Term Effectiveness and Reduction in Insulin Requirements in Patients With Type 2 Diabetes Treated With IdegLira in a Real-World Setting [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
- [26] Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 3059 - 3068
- [27] iGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real-world study [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1249 - 1260
- [30] Safety and effectiveness of insulin therapy in Chinese patients with type 2 diabetes mellitus: findings from the real-world SEAS study [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16252 - 16262